Dulce Alfaiate

706 total citations
15 papers, 370 citations indexed

About

Dulce Alfaiate is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Dulce Alfaiate has authored 15 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Dulce Alfaiate's work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease Diagnosis and Treatment (5 papers). Dulce Alfaiate is often cited by papers focused on Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease Diagnosis and Treatment (5 papers). Dulce Alfaiate collaborates with scholars based in France, Switzerland and Germany. Dulce Alfaiate's co-authors include Sophie Clément, Francesco Negro, Paul Dény, Nicolas Goossens, David Durantel, Jc Cortay, Camille Sureau, Barbara Testoni, Maud Michelet and Fabien Zoulim and has published in prestigious journals such as Nature Communications, Scientific Reports and Journal of Hepatology.

In The Last Decade

Dulce Alfaiate

12 papers receiving 364 citations

Peers

Dulce Alfaiate
Sung Hyun Ahn South Korea
Vitina Sozzi Australia
Tuan Nguyen United States
Choi-Lai Tiong-Yip United States
Dulce Alfaiate
Citations per year, relative to Dulce Alfaiate Dulce Alfaiate (= 1×) peers Till Bornscheuer

Countries citing papers authored by Dulce Alfaiate

Since Specialization
Citations

This map shows the geographic impact of Dulce Alfaiate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dulce Alfaiate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dulce Alfaiate more than expected).

Fields of papers citing papers by Dulce Alfaiate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dulce Alfaiate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dulce Alfaiate. The network helps show where Dulce Alfaiate may publish in the future.

Co-authorship network of co-authors of Dulce Alfaiate

This figure shows the co-authorship network connecting the top 25 collaborators of Dulce Alfaiate. A scholar is included among the top collaborators of Dulce Alfaiate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dulce Alfaiate. Dulce Alfaiate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Conrad, Anne, et al.. (2025). Partner treatment strategies for Chlamydia and Gonorrhea: Time for a reappraisal. Infectious Diseases Now. 55(3). 105038–105038.
2.
Lédinghen, Victor de, Karine Lacombe, Stanislas Pol, et al.. (2024). WED-410 Sustained virological response after treatment with Bulevirtide in HDV patients. Data from the french multicenter real-life cohort. Journal of Hepatology. 80. S802–S802. 5 indexed citations
3.
Sobolewski, Cyril, Étienne Lefai, Dulce Alfaiate, et al.. (2023). ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance. Scientific Reports. 13(1). 6767–6767. 1 indexed citations
4.
Alfaiate, Dulce, Pierre Pradat, Isabelle Martin, et al.. (2023). Prevalence and incidence of delta hepatitis in HIV-HBV coinfected patients in the Dat’AIDS cohort. Journal of Hepatology. 78. S876–S877. 1 indexed citations
5.
Saker, Kahina, Bruno Pozzetto, Vanessa Escuret, et al.. (2022). Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects. Journal of Clinical Virology. 152. 105169–105169. 13 indexed citations
6.
8.
Michelet, Maud, Dulce Alfaiate, Caroline Pons, et al.. (2021). Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro. JHEP Reports. 4(3). 100415–100415. 7 indexed citations
9.
Alfaiate, Dulce, et al.. (2020). Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. Journal of Hepatology. 73(3). 533–539. 109 indexed citations
10.
Cortay, Jc, Camille Sureau, Susanne Müller, et al.. (2020). Hepatitis Delta Virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replication. Nature Communications. 11(1). 419–419. 23 indexed citations
11.
Clément, Sophie, et al.. (2019). A review on hepatitis D: From virology to new therapies. Journal of Advanced Research. 17. 3–15. 78 indexed citations
12.
Cortay, Jc, et al.. (2018). Réplication du génome du virus de l’hépatite delta : un rôle pour la petite protéine delta S-HDAg. médecine/sciences. 34(10). 833–841. 2 indexed citations
13.
Alfaiate, Dulce & David Durantel. (2017). Un nouveau modèle murin immunocompétent pour l’étude de l’infection par le virus de l’hépatite D. médecine/sciences. 33(6–7). 570–573.
14.
Alfaiate, Dulce, Julie Lucifora, Maud Michelet, et al.. (2016). HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes. Antiviral Research. 136. 19–31. 65 indexed citations
15.
Alfaiate, Dulce, Paul Dény, & David Durantel. (2015). Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options. Antiviral Research. 122. 112–129. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026